OMI icon

Owens & Minor

4.97 USD
-0.23
4.42%
At close Updated Sep 16, 3:20 PM EDT
1 day
-4.42%
5 days
-11.09%
1 month
-8.81%
3 months
-37.25%
6 months
-49.65%
Year to date
-61.32%
1 year
-69.03%
5 years
-67.04%
10 years
-85.61%
 

About: Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Employees: 13,500

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

6% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 83

2% more capital invested

Capital invested by funds: $670M [Q1] → $681M (+$11M) [Q2]

0.77% more ownership

Funds ownership: 96.1% [Q1] → 96.87% (+0.77%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

3% less funds holding

Funds holding: 242 [Q1] → 234 (-8) [Q2]

11% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $1.69M

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4.75
4% downside
Avg. target
$6.35
28% upside
High target
$7
41% upside

5 analyst ratings

positive
60%
neutral
0%
negative
40%
JP Morgan
Lisa Gill
$6
Underweight
Maintained
27 Aug 2025
UBS
Kevin Caliendo
$7
Buy
Maintained
13 Aug 2025
Baird
Eric Coldwell
$7
Outperform
Maintained
12 Aug 2025
Citigroup
Daniel Grosslight
$7
Buy
Maintained
12 Aug 2025
B of A Securities
Allen Lutz
$4.75
Underperform
Maintained
12 Aug 2025

Financial journalist opinion

Neutral
Business Wire
22 hours ago
Apria and Byram Join New Optum Preferred DME Network
RICHMOND, Va.--(BUSINESS WIRE)--Effective September 1, 2025, Apria and Byram, part of the Owens & Minor family, entered a new national provider agreement with Optum Health.
Apria and Byram Join New Optum Preferred DME Network
Neutral
PRNewsWire
10 days ago
AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance.
AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Neutral
Benzinga
1 month ago
Owens & Minor Analysts Boost Their Forecasts After Q2 Results
Owens & Minor, Inc. OMI reported worse-than-expected second-quarter earnings on Monday.
Owens & Minor Analysts Boost Their Forecasts After Q2 Results
Negative
Seeking Alpha
1 month ago
Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade)
Owens & Minor, Inc.'s disastrous performance, weak margins, and strategic missteps have eroded investor confidence and driven OMI stock down 70% in a year. The planned sale of its core Products & Healthcare Services business highlights severe financial distress, with all proceeds earmarked for debt reduction. Guidance was slashed dramatically, revealing ongoing operational weakness and a multi-year turnaround with little benefit for equity holders in the near term.
Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade)
Neutral
Seeking Alpha
1 month ago
Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript
Owens & Minor, Inc. (NYSE:OMI ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants Jacqueline Marcus - IR, Alpha IR Group LLC Edward A. Pesicka - President, CEO & Director Jonathan A.
Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript
Negative
Benzinga
1 month ago
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
U.S. stocks traded mixed this morning, with the Nasdaq Composite declining around 0.2% on Monday.
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
Neutral
Business Wire
1 month ago
Owens & Minor Reports Second Quarter 2025 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. “We are in the final stages of our robust process for the divest.
Owens & Minor Reports Second Quarter 2025 Financial Results
Neutral
Benzinga
1 month ago
Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings
Owens & Minor, Inc. OMI will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.
Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings
Neutral
Zacks Investment Research
1 month ago
Seeking Clues to Owens & Minor (OMI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Owens & Minor (OMI) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Seeking Clues to Owens & Minor (OMI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Neutral
Business Wire
1 month ago
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All inter.
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
Charts implemented using Lightweight Charts™